Norton Pulmonary Specialists

Louisville, Kentucky 40241

4 studies enrolling now · 19 studies all time

What they study most

Cardiovascular Diseases, Fibrosis, Hypertension, Pulmonary, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Diseases, Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Progressive Pulmonary Fibrosis, Pulmonary Arterial Hypertension, Pulmonary Fibrosis, Pulmonary Hypertension

Studies at this site

• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH — Recruiting now
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) — Recruiting now
• A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489 — Recruiting now
• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — Enrolling by invitation
• Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) — Running, not enrolling
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension — Running, not enrolling
• Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis — Completed
• A Study of Mosliciguat in PH-ILD — Running, not enrolling
• A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) — Completed
• A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE) — Completed
• A Registry for Patients Taking Uptravi — Completed
• A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH) — Completed
• A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension — Stopped early
• A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis — Status unconfirmed
• Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension — Completed
• Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy — NO_LONGER_AVAILABLE